Wilhelm G. Struff

406 total citations
13 papers, 306 citations indexed

About

Wilhelm G. Struff is a scholar working on Infectious Diseases, Epidemiology and Hematology. According to data from OpenAlex, Wilhelm G. Struff has authored 13 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Wilhelm G. Struff's work include Viral gastroenteritis research and epidemiology (4 papers), Respiratory viral infections research (2 papers) and Platelet Disorders and Treatments (2 papers). Wilhelm G. Struff is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Respiratory viral infections research (2 papers) and Platelet Disorders and Treatments (2 papers). Wilhelm G. Struff collaborates with scholars based in Germany, United Kingdom and Poland. Wilhelm G. Struff's co-authors include G. Sprotte, Jerard Seghatchian, Stefan Reichenberg, Susanne Modrow, Heiko Pfister, Juha Lindner, Annelie Plentz, Sandra Zehentmeier, Hugo Segerer and R. Lissner and has published in prestigious journals such as European Journal of Clinical Pharmacology, Journal of Clinical Virology and Haemophilia.

In The Last Decade

Wilhelm G. Struff

13 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilhelm G. Struff Germany 9 118 88 64 48 44 13 306
Barbara Glanemann United Kingdom 12 62 0.5× 110 1.3× 83 1.3× 100 2.1× 42 1.0× 37 432
Kalayanee Khupulsup Thailand 8 76 0.6× 172 2.0× 73 1.1× 13 0.3× 15 0.3× 24 336
Peter Volkers Germany 13 58 0.5× 42 0.5× 17 0.3× 45 0.9× 30 0.7× 25 401
M J Smith United Kingdom 6 103 0.9× 147 1.7× 46 0.7× 54 1.1× 62 1.4× 7 342
Roger A. Hostutler United States 11 33 0.3× 73 0.8× 168 2.6× 107 2.2× 15 0.3× 20 410
Katerina K. Adamama‐Moraitou Greece 11 86 0.7× 71 0.8× 51 0.8× 103 2.1× 15 0.3× 25 385
Kiyanna Williams United States 8 90 0.8× 119 1.4× 19 0.3× 30 0.6× 19 0.4× 15 272
Daniel Stulberg United States 10 53 0.4× 136 1.5× 9 0.1× 21 0.4× 36 0.8× 12 456
Albina Innerhofer Austria 8 96 0.8× 113 1.3× 87 1.4× 31 0.6× 20 0.5× 10 327
Neusa P. Silva Brazil 11 112 0.9× 23 0.3× 42 0.7× 50 1.0× 42 1.0× 14 309

Countries citing papers authored by Wilhelm G. Struff

Since Specialization
Citations

This map shows the geographic impact of Wilhelm G. Struff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilhelm G. Struff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilhelm G. Struff more than expected).

Fields of papers citing papers by Wilhelm G. Struff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilhelm G. Struff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilhelm G. Struff. The network helps show where Wilhelm G. Struff may publish in the future.

Co-authorship network of co-authors of Wilhelm G. Struff

This figure shows the co-authorship network connecting the top 25 collaborators of Wilhelm G. Struff. A scholar is included among the top collaborators of Wilhelm G. Struff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilhelm G. Struff. Wilhelm G. Struff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Seghatchian, Jerard, Wilhelm G. Struff, & Stefan Reichenberg. (2011). Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction. Transfusion Medicine and Hemotherapy. 38(1). 55–64. 66 indexed citations
2.
Lindner, Juha, Sandra Zehentmeier, Annelie Plentz, et al.. (2008). Humoral Immune Response Against Human Bocavirus VP2 Virus-Like Particles. Viral Immunology. 21(4). 443–450. 50 indexed citations
3.
Struff, Wilhelm G. & G. Sprotte. (2008). Bovine colostrum as a biologic in clinical medicine: A review – Part II: Clinical studies. International Journal of Clinical Pharmacology and Therapeutics. 46(5). 211–225. 56 indexed citations
4.
Lindner, Juha, et al.. (2008). Clinical and epidemiological aspects of human bocavirus infection. Journal of Clinical Virology. 43(4). 391–395. 23 indexed citations
5.
Struff, Wilhelm G. & G. Sprotte. (2007). Bovine colostrum as a biologic in clinical medicine: a review.Part I: Biotechnological standards, pharmacodynamic and pharmacokinetic characteristics and principles of treatment. International Journal of Clinical Pharmacology and Therapeutics. 45(4). 193–202. 34 indexed citations
6.
Struff, Wilhelm G., et al.. (2005). Safety monitoring of a polyvalent immunoglobulin preparation: documentation of 15,548 administrations. International Journal of Clinical Pharmacology and Therapeutics. 43(9). 420–428. 11 indexed citations
7.
Rokicka-Milewska, R, S Łopaciuk, A B Skotnicki, et al.. (2004). Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A. Haemophilia. 10(5). 438–448. 13 indexed citations
8.
Schmidt, Herbert, R. Lissner, Wilhelm G. Struff, Oliver C. Thamm, & Helge Karch. (2002). Antibody Reactivity of a Standardized Human Serum Protein Solution Against a Spectrum of Microbial Pathogens and Toxins: Comparison with Fresh Frozen Plasma. Therapeutic Apheresis. 6(2). 145–153. 8 indexed citations
9.
Lissner, R., Wilhelm G. Struff, Ingo B. Autenrieth, Barry G. Woodcock, & Helge Karch. (1999). Efficacy and potential clinical applications of pentaglobin®, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. The European Journal of Surgery. 165(S9). 17–25. 13 indexed citations
10.
Thürmann, Petra, R. Lissner, Wilhelm G. Struff, & S. Harder. (1999). Pharmacokinetics of oxypolygelatine in healthy volunteers. European Journal of Clinical Pharmacology. 55(1). 49–51. 2 indexed citations
11.
Harrer, Thomas, Johannes Schwab, Wilhelm G. Struff, et al.. (1998). Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS. Infection. 26(6). 368–374. 2 indexed citations
12.
Gaede, Karoline I., Gernot Zissel, U. Schwuléra, et al.. (1997). Spontaneous and interleukin-2-modulated cytokine release by bronchoalveolar cells in pulmonary malignancy.. PubMed. 8(4). 395–400. 3 indexed citations
13.
Lorenz, J, Kai Wilhelm, M. Kessler, et al.. (1996). Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects.. PubMed. 2(7). 1115–22. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026